for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Inovio partners with Advaccine to commercialize COVID-19 vaccine in China

Jan 4 (Reuters) - Inovio Pharmaceuticals Inc has partnered with Advaccine Biopharmaceuticals Suzhou Co Ltd to manufacture and commercialize its COVID-19 vaccine candidate in China, the companies said on Monday.

Under the agreement, Advaccine will have the exclusive right to develop, manufacture and commercialize Inovio’s vaccine candidate, INO-4800, in the country. (Reporting by Mrinalika Roy in Bengaluru; Editing by Anil D’Silva)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up